DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Butzkueven H, Kappos L, Pellegrini F. , et al; TYSABRI Observational Program (TOP) Investigators.
Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results.
J Neurol Neurosurg Psychiatry 2014;
85 (11) 1190-1197
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.